Sort
48,018 grants matching “immunotherapy”
CCR4-IL2 Bispecific Immunotoxin for Targeted Therapy of Cutaneous T-Cell Lymphoma
$875,832Zhirui Wang · Rock Immune Llc · R42 · FY2023 · CA
PEDIATRIC AIDS CLINICAL TRIALS UNIT
$875,817Duke University · U01 · FY2000 · AI
METABOLIC REMODELING OF THE TUMOR MICROENVIRONMENT TO IMPROVE THE EFFICACY OF IMMUNOTHERAPY
$875,549University Of Pittsburgh - Of The Commonwealth System Of Higher Education · · FY2018 · Defense Health Agency
Clinical Program in Pediatric Sarcomas
$875,448Crystal Mackall · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Biomaterials for Targeted Modulation of Conventional Type 1 Dendritic Cells
$875,408Hua Wang · University Of Illinois At Urbana-Champaign · R01 · FY2025 · CA
Clinical Analysis Of Disorders Of Hearing And Balance
$874,689Carmen Crowell Brewer · National Institute On Deafness And Other Communication Disorders · ZIA · FY2010 · DC
Treating non-small cell lung tumors with a novel inhaled dry powder chemotherapeutic formulation
$874,452Bryce Beverlin II · Quench Medical, Inc. · R44 · FY2024 · CA
Dendritic Cell-Based Immunotherapy for HIV Infection
$874,433University Of Pittsburgh At Pittsburgh · P01 · FY2004 · AI
Impact of Body Composition and Related Inflammatory and Immune States on Prognosis of Non-Muscle Invasive Bladder Cancer
$874,216Marilyn L Kwan · Kaiser Foundation Research Institute · U01 · FY2025 · CA
Leadership Center Administration
$874,191Robert A Wood · Johns Hopkins University · UM2 · FY2023 · AI
Mediators of fatty liver disease during HIV/SIV and cART treatment
$873,771Donald L Sodora · Seattle Children'S Hospital · R01 · FY2020 · AI
Clinical Protocol and Data Management
$873,699Carrie B Lee · Univ Of North Carolina Chapel Hill · P30 · FY2025 · CA
Basic Research Support for the CCR
$873,318Thomas A Misteli · Division Of Basic Sciences - Nci · ZIC · FY2018 · CA
Genomic characterization and development of therapies for pediatric sarcoma
$872,696John Shern · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Molecular Pathogenesis of Neoplasia
$872,468John Heiss · National Institute Of Neurological Disorders And Stroke · ZIA · FY2025 · NS
Role of Tumor Stroma in Therapeutic Response and Resistance
$872,340Lynda Chin · University Of Tx Md Anderson Can Ctr · U54 · FY2012 · CA
Immuno-Targeted Therapy for Melanoma
$872,264Antoni Ribas · University Of California Los Angeles · R35 · FY2019 · CA
Humanized Antibodies Derived from Chimpanzee Fabs that Neutralize Flaviviruses
$872,096Ching-Juh Lai · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
The Immunobiology of Marrow Allografts for Leukemia
$872,075Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2007 · CA
Molecular Pharmacology Lab
$872,000Lynn Briscoe · Leidos Biomedical Research, Inc. · N01 · FY2024 · CA
Studying factors controlling cancer progression and immune recognition in mouse models
$871,800Tyler E Jacks · Massachusetts Institute Of Technology · R35 · FY2022 · CA
Organ specific microenvironmental regulation of metastasis
$871,771Kandice Tanner · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Center for Interventional Oncology
$871,672Bradford J Wood · Division Of Basic Sciences - Nci · ZID · FY2020 · CA
ePACE: automation platforms for adaptable and scalable continuous evolution of biomolecules with therapeutic potential
$871,502Ahmad Samir Khalil · Boston University (Charles River Campus) · R01 · FY2023 · EB
Imaging intracerebral and systemic T cell immunity in patients with Alzheimer's disease using 18F-F-AraG
$871,261Jelena Levi · Cellsight Technologies, Inc. · R44 · FY2025 · AG